311 related articles for article (PubMed ID: 20044069)
1. The pituitary stalk interruption syndrome: endocrine features and benefits of growth hormone therapy.
El Chehadeh S; Bensignor C; de Monléon JV; Méjean N; Huet F
Ann Endocrinol (Paris); 2010 Mar; 71(2):102-10. PubMed ID: 20044069
[TBL] [Abstract][Full Text] [Related]
2. Growth and Adult Height during Human Growth Hormone Treatment in Chinese Children with Multiple Pituitary Hormone Deficiency Caused by Pituitary Stalk Interruption Syndrome: A Single Centre Study.
Wang F; Han J; Wang Z; Shang X; Li G
J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):71-78. PubMed ID: 31475508
[TBL] [Abstract][Full Text] [Related]
3. Long-term evolution of endocrine disorders and effect of GH therapy in 35 patients with pituitary stalk interruption syndrome.
Tauber M; Chevrel J; Diene G; Moulin P; Jouret B; Oliver I; Pienkowski C; Sevely A
Horm Res; 2005; 64(6):266-73. PubMed ID: 16260897
[TBL] [Abstract][Full Text] [Related]
4. Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment: Retesting early in the course of GH treatment.
Vuralli D; Gonc EN; Ozon ZA; Alikasifoglu A; Kandemir N
Growth Horm IGF Res; 2017 Jun; 34():31-37. PubMed ID: 28511077
[TBL] [Abstract][Full Text] [Related]
5. Development of growth hormone and adrenocorticotropic hormone deficiencies in patients with prenatal or perinatal-onset hypothalamic hypopituitarism having invisible or thin pituitary stalk on magnetic resonance imaging.
Miyamoto J; Hasegawa Y; Ohnami N; Onigata K; Kinoshita E; Nishi Y; Tachibana K; Hasegawa T
Endocr J; 2001 Jun; 48(3):355-62. PubMed ID: 11523907
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic growth hormone deficiency: presentation, diagnostic and treatment during childhood.
Pinto G; Adan L; Souberbielle JC; Thalassinos C; Brunelle F; Brauner R
Ann Endocrinol (Paris); 1999 Sep; 60(3):224-31. PubMed ID: 10520414
[TBL] [Abstract][Full Text] [Related]
8. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of growth hormone (GH) deficiency: comparison of pituitary stalk interruption syndrome and transient GH deficiency.
Louvel M; Marcu M; Trivin C; Souberbielle JC; Brauner R
BMC Pediatr; 2009 May; 9():29. PubMed ID: 19419564
[TBL] [Abstract][Full Text] [Related]
10. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
Darendeliler F; Lindberg A; Wilton P
Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
[TBL] [Abstract][Full Text] [Related]
11. Response to growth hormone treatment in very young patients with growth hormone deficiencies and mini-puberty.
Çetinkaya S; Poyrazoğlu Ş; Baş F; Ercan O; Yıldız M; Adal E; Bereket A; Abalı S; Aycan Z; Erdeve ŞS; Berberoğlu M; Şıklar Z; Tayfun M; Darcan Ş; Mengen E; Bircan İ; Jones FMÇ; Şimşek E; Papatya ED; Özbek MN; Bolu S; Abacı A; Büyükinan M; Darendeliler F
J Pediatr Endocrinol Metab; 2018 Jan; 31(2):175-184. PubMed ID: 29353264
[TBL] [Abstract][Full Text] [Related]
12. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
Léger J; Danner S; Simon D; Garel C; Czernichow P
J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
[TBL] [Abstract][Full Text] [Related]
13. Final height and growth hormone secretion after completion of growth hormone therapy in patients with idiopathic growth hormone deficiency and with abnormalities of the hypothalamic-pituitary region.
Hilczer M; Smyczynska J; Stawerska R; Lewinski A
Neuro Endocrinol Lett; 2005 Feb; 26(1):19-24. PubMed ID: 15726014
[TBL] [Abstract][Full Text] [Related]
14. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
[TBL] [Abstract][Full Text] [Related]
15. Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings.
Coutant R; Rouleau S; Despert F; Magontier N; Loisel D; Limal JM
J Clin Endocrinol Metab; 2001 Oct; 86(10):4649-54. PubMed ID: 11600520
[TBL] [Abstract][Full Text] [Related]
16. Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency.
Blum WF; Deal C; Zimmermann AG; Shavrikova EP; Child CJ; Quigley CA; Drop SL; Cutler GB; Rosenfeld RG
Eur J Endocrinol; 2014 Jan; 170(1):13-21. PubMed ID: 24088548
[TBL] [Abstract][Full Text] [Related]
17. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
Ross JL; Lee PA; Gut R; Germak J
Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of 13 cases with growth hormone deficiency combined with pituitary stalk interruption].
Wang GL; Fu JF; Wang CL; Liang L
Zhonghua Er Ke Za Zhi; 2010 Apr; 48(4):305-7. PubMed ID: 20654023
[TBL] [Abstract][Full Text] [Related]
19. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies.
Maghnie M; Ambrosini L; Cappa M; Pozzobon G; Ghizzoni L; Ubertini MG; di Iorgi N; Tinelli C; Pilia S; Chiumello G; Lorini R; Loche S
J Clin Endocrinol Metab; 2006 Aug; 91(8):2900-5. PubMed ID: 16684828
[TBL] [Abstract][Full Text] [Related]
20. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
